Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venigalla Pratap Mouli

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Gastroenterology|October 16, 2012
Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysisVenigalla Pratap Mouli, Vishnubhatla Sreenivas, Pramod Kumar Garg
The American Journal of Gastroenterology|February 8, 2020
Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-AnalysisSaurabh Kedia, Venigalla Pratap Mouli, Nagesh Kamat, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2014
Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trialVenigalla Pratap Mouli, Jaya Benjamin, Mamta Bhushan Singh, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 24, 2017
Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trialSaurabh Kedia, Vikram Bhatia, Sandeep Thareja, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|May 14, 2015
Computerized tomography-based predictive model for differentiation of Crohn's disease from intestinal tuberculosisSaurabh Kedia, Raju Sharma, Birinder Nagi, et al.
Journal of Crohn'S & Colitis|May 13, 2015
Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activitySaurabh Srivastava, Saurabh Kedia, Sushil Kumar, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|February 10, 2015
Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotypeBikramjit Singh, Saurabh Kedia, Gauree Konijeti, et al.
Journal of Digestive Diseases|December 17, 2015
Frequency, natural course and clinical significance of symptomatic terminal ileitisSaurabh Kedia, Lalit Kurrey, Venigalla Pratap Mouli, et al.
Intestinal Research|October 11, 2018
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in IndiaAshish Agarwal, Saurabh Kedia, Saransh Jain, et al.
Intestinal Research|May 20, 2017
Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysisSaurabh Kedia, Raju Sharma, Vishnubhatla Sreenivas, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Gastroenterology|October 16, 2012
Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysisVenigalla Pratap Mouli, Vishnubhatla Sreenivas, Pramod Kumar Garg
The American Journal of Gastroenterology|February 8, 2020
Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-AnalysisSaurabh Kedia, Venigalla Pratap Mouli, Nagesh Kamat, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 1, 2014
Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trialVenigalla Pratap Mouli, Jaya Benjamin, Mamta Bhushan Singh, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 24, 2017
Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trialSaurabh Kedia, Vikram Bhatia, Sandeep Thareja, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|May 14, 2015
Computerized tomography-based predictive model for differentiation of Crohn's disease from intestinal tuberculosisSaurabh Kedia, Raju Sharma, Birinder Nagi, et al.
Journal of Crohn'S & Colitis|May 13, 2015
Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activitySaurabh Srivastava, Saurabh Kedia, Sushil Kumar, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|February 10, 2015
Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotypeBikramjit Singh, Saurabh Kedia, Gauree Konijeti, et al.
Journal of Digestive Diseases|December 17, 2015
Frequency, natural course and clinical significance of symptomatic terminal ileitisSaurabh Kedia, Lalit Kurrey, Venigalla Pratap Mouli, et al.
Intestinal Research|October 11, 2018
High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in IndiaAshish Agarwal, Saurabh Kedia, Saransh Jain, et al.
Intestinal Research|May 20, 2017
Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysisSaurabh Kedia, Raju Sharma, Vishnubhatla Sreenivas, et al.
Pageof 2